![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
0
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
1. (+)-prostaglandin A2
2. (5z,13e,15s)-15-hydroxy-9-oxoprosta-5, 10,13-triene-1-oic Acid
3. (z)-7-((1r,2s)-2-((e)-(3s)-3-hydroxyoct-1-enyl)-5-oxocyclopent-3-enyl)hept-5-enoic Acid
4. Medullin
5. Pga2
1. Medullin
2. Pga2
3. 13345-50-1
4. (+)-prostaglandin A2
5. 5,6-cis-pga2
6. (15s)-pga2
7. (+)-prostaglandin A(sup 2)
8. K6vt5bdy9e
9. 15(s)-prostaglandin A2
10. Chebi:27820
11. Prosta-5,10,13-trien-1-oic Acid, 15-hydroxy-9-oxo-, (5z,13e,15s)-
12. 9-oxo-15s-hydroxy-5z,10z,13e-prostatrienoic Acid
13. (z)-7-[(1r,2s)-2-[(e,3s)-3-hydroxyoct-1-enyl]-5-oxocyclopent-3-en-1-yl]hept-5-enoic Acid
14. 15(s)-hydroxy-9-oxo-5-cis-10,13-trans-prostatrienoic Acid
15. Nsc 165561
16. Pga2 (prostaglandin A2)
17. 15(s)-hydroxy-9-oxo-5-cis-10,13-trans-prostenoic Acid
18. Pga(sup 2)
19. Prosta-5,10,13-trien-1-oicacid, 15-hydroxy-9-oxo-, (5z,13e,15s)-
20. 5,6-cis-pga(sup 2)
21. Mls000069589
22. Prostaglandin A(sup 2)
23. Unii-k6vt5bdy9e
24. (155)-pga2
25. Brn 2221844
26. Nsc-165561
27. (~{z})-7-[(1~{r},5~{s})-2-oxidanylidene-5-[(~{e},3~{s})-3-oxidanyloct-1-enyl]cyclopent-3-en-1-yl]hept-5-enoic Acid
28. Smr000058790
29. Pga2(prostaglandin A2)
30. Bspbio_001460
31. Bml1-f02
32. Gtpl6279
33. Schembl2115595
34. Chembl1084643
35. Dtxsid20864388
36. Prostaglandin A2 (pga2)
37. Hms1361i22
38. Hms1791i22
39. Hms1989i22
40. Hms3402i22
41. Hms3648i11
42. Zinc4521813
43. (5z,13e,15s)-15-hydroxy-9-oxoprosta-5, 10,13-triene-1-oic Acid
44. (5z,13e,15s)-15-hydroxy-9-oxoprosta-5,10,13-trien-1-oic Acid
45. Lmfa03010035
46. Prosta-5,10-13-trien-1-oic Acid, 15-hydroxy-9-oxo-, (5z,13e,15s)-
47. (z)-7-((1r,2s)-2-((e)-(3s)-3-hydroxyoct-1-enyl)-5-oxocyclopent-3-enyl)hept-5-enoic Acid
48. 5-heptenoic Acid, 7-(2-(3-hydroxy-1-octenyl)-5-oxo-3-cyclopenten-1-yl)- (van)
49. Idi1_033930
50. Ncgc00022061-03
51. Ncgc00022061-04
52. Ncgc00022061-05
53. Hy-113041
54. Cs-0059420
55. Dinoprostone Impurity D [ep Impurity]
56. C05953
57. Sr-01000946222
58. Sr-01000946222-1
59. 15(s)-hydroxy-9-oxo-5-cis-10,13-trans-prostenoate
60. Brd-k34782918-001-02-5
61. Q27088462
62. 15a-hydroxy-9-oxo-cis-5,10,trans-13-prostatrienoate
63. 15(s)-hydroxy-9-oxo-5-cis-10,13-trans-prostatrienoate
64. 15a-hydroxy-9-oxo-cis-5,10,trans-13-prostatrienoic Acid
65. 15a-hydroxy-9-oxo-cis-5,10,trans-13-prostatrienecarboxylate
66. 362927f3-3a3e-47bc-84c3-c32a293aa956
67. 15.alpha.-hydroxy-9-oxo-cis-5,10,trans-13-prostatrienoic Acid
68. 15a-hydroxy-9-oxo-cis-5,10,trans-13-prostatrienecarboxylic Acid
69. 15.alpha.-hydroxy-9-oxo-cis-5,10,trans-13-prostatrienecarboxylic Acid
70. (z)-7-[(1r,2s)-2-[(e,3s)-3-hydroxyoct-1-enyl]-5-oxo-1-cyclopent-3-enyl]hept-5-enoic Acid
71. (z)-7-[(1r,2s)-2-[(e,3s)-3-hydroxyoct-1-enyl]-5-oxo-cyclopent-3-en-1-yl]hept-5-enoic Acid
72. Dinoprostone Impurity, (5z,13e,15s)-15-hydroxy-9-oxoprosta-5, 10,13-triene-1-oic Acid- [usp Impurity]
Molecular Weight | 334.4 g/mol |
---|---|
Molecular Formula | C20H30O4 |
XLogP3 | 3.6 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 12 |
Exact Mass | 334.21440943 g/mol |
Monoisotopic Mass | 334.21440943 g/mol |
Topological Polar Surface Area | 74.6 Ų |
Heavy Atom Count | 24 |
Formal Charge | 0 |
Complexity | 476 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 3 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 2 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |